Recombinate: Uses, Dosing, Side Effects, Storage, and Administration
Recombinate is an FDA-approved intravenous (IV) factor VIII replacement therapy used to control bleeding episodes in people with hemophilia A. It is also used to manage bleeding before, during, and after surgery in people with hemophilia A.
